Mind-focused well being tech firm Linus Well being introduced that it has snapped up Kinesis Well being Applied sciences, an Irish startup centered on physical-function evaluation.
A College Faculty Dublin spin-out, Kinesis focuses on digitally assessing gait, stability, mobility, fall threat and frailty.
In the meantime, Boston-based Linus Well being focuses on offering digital instruments to assist clinicians assess cognitive and mind dysfunction. The corporate’s evaluation can be utilized in a lot of settings, together with analysis, senior residing and scientific care, in keeping with its webpage.
Linus Well being stated that this acquisition will assist it broaden its scope of providers to incorporate each bodily and cognitive assessments, noting that the 2 are sometimes linked.
“The extra we will uncover about an individual’s mind well being, the quicker we’ll be capable of assist suppliers intervene when one thing is awry,” David Bates, CEO of Linus Well being, stated in an announcement. “Buying Kinesis offers the chance to speed up our progress in the important thing areas of gait, stability, and mobility – and garner associated insights to form our understanding of a affected person’s well being and related dangers to higher inform our scientific steerage and care-plan suggestions. We’re wanting ahead to collaborating with the Kinesis workforce to reinforce our mixed impression.”
WHY IT MATTERS
In response to the Facilities for Illness Management and Prevention, greater than 16 million people within the U.S. have cognitive impairment. That quantity is predicted to develop because the U.S. inhabitants continues to age.
Whereas Linus Well being has centered on mind well being for a while, this new acquisition will assist it soar into the physical-function area. Bodily perform may be linked to dementia, in keeping with a research revealed in Neuroepidemiology.
THE LARGER TREND
Linus Well being, which scored $55 million in Sequence B funding in July 2021, has been making strikes within the partnership area. In 2021, it teamed up with Cognito Therapeutics, a digital-therapeutic firm centered on treating neurodegenerative illnesses like Alzheimer’s.
Kinesis has been working within the digital-health area since 2014. In 2015, the corporate revealed its app-connected wearable sensors that might assess fall threat.
Massive tech gamers are additionally curious about monitoring cognitive decline. In 2021, Apple and Biogen launched a digital research on cognitive decline that’s at present being carried out on Apple Watch and iPhones.